Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
303
-
Total 13F shares, excl. options
-
130M
-
Shares change
-
+925K
-
Total reported value, excl. options
-
$4.66B
-
Value change
-
+$29M
-
Put/Call ratio
-
0.58
-
Number of buys
-
116
-
Number of sells
-
-173
-
Price
-
$35.74
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q1 2023
377 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q1 2023.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 303 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 130M shares
of 159M outstanding shares and own 82.23% of the company stock.
Largest 10 shareholders include FMR LLC (21.4M shares), VANGUARD GROUP INC (14M shares), T. Rowe Price Investment Management, Inc. (13.1M shares), Bellevue Group AG (9.51M shares), BlackRock Inc. (8.98M shares), Clearbridge Investments, LLC (5.39M shares), STATE STREET CORP (4.07M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.93M shares), Tweedy, Browne Co LLC (3.54M shares), and Deep Track Capital, LP (2.83M shares).
This table shows the top 303 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.